The patented Purafil SP and Puraward filters, with which the Purashield 500 devices are equipped, remove 99.46% of the solutions with viral load SARS-CoV-2, ie the coronavirus that has caused the Covid-19 pandemic. At the same time, there are corresponding efficacy studies against H1N1, H7N9, SARS, MERS viruses and E. coli, Staphylococcus Albus, Candida Albicans.
Stay safe, healthy and productive. Offer increased hygiene, safety and protection with PuraShield’s state-of-the-art American filtration and air purification systems. The only ones with independent laboratory efficacy studies against Sars-Cov-2 and H1N1 viruses.
American, patented molecular filtration technology tested in large-scale industrial applications.